Europe Pharmaceutical Regulatory Affairs Market Size & Outlook
Related Markets
Europe pharmaceutical regulatory affairs market highlights
- The Europe pharmaceutical regulatory affairs market generated a revenue of USD 2,146.9 million in 2024.
- The market is expected to grow at a CAGR of 6.1% from 2025 to 2030.
- In terms of segment, outsourcing was the largest revenue generating service provider in 2024.
- Outsourcing is the most lucrative service provider segment registering the fastest growth during the forecast period.
- Country-wise, UK is expected to register the highest CAGR from 2025 to 2030.
Europe data book summary
| Market revenue in 2024 | USD 2,146.9 million |
| Market revenue in 2030 | USD 3,061.4 million |
| Growth rate | 6.1% (CAGR from 2025 to 2030) |
| Largest segment | Outsourcing |
| Fastest growing segment | Outsourcing |
| Historical data covered | 2018 - 2023 |
| Base year for estimation | 2024 |
| Forecast period covered | 2025 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | In-house, Outsourcing |
Other key industry trends
- In terms of revenue, Europe region accounted for 22.7% of the global pharmaceutical regulatory affairs market in 2024.
- Globally, Asia Pacific is projected to lead the regional market in terms of revenue in 2030.
- Asia Pacific is the fastest growing regional market and is projected to reach USD 5,623.9 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Pharmaceutical Regulatory Affairs Market Scope
Pharmaceutical Regulatory Affairs Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Charles River Laboratories International, Inc. | View profile | - | - | - |
| Parexel International Corporation | View profile | - | - | - |
| IQVIA Inc. | View profile | - | - | - |
| Freyr Solutions | View profile | 1001-5000 | Princeton, New Jersey, United States, North America | http://www.freyrsolutions.com/ |
| PharmaLex | View profile | 1001-5000 | Friedrichsdorf, Hessen, Germany, Europe | http://www.pharmalex.com/ |
| Labcorp Drug Development | View profile | 10001+ | Princeton, New Jersey, United States, North America | https://drugdevelopment.labcorp.com |
| Pharmexon | View profile | 11-50 | Prague, Hlavni mesto Praha, Czech Republic, Europe | https://pharmexon.com |
| Wuxi AppTec Co Ltd | View profile | 41116 | 288 Fute Zhong Road, Waigaoqiao Free Trade Zone, Shanghai, China, People's Republic of, 200131 | https://www.wuxiapptec.com |
| Icon PLC | View profile | 41150 | South County Business Park, Leopardstown, Dublin, Ireland, D18 X5R3 | https://www.iconplc.com |
| Genpact Ltd | View profile | 131000 | 22 Victoria Street, Canon's Court, Hamilton, Bermuda, HM 12 | https://www.genpact.com |
Europe pharmaceutical regulatory affairs market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to pharmaceutical regulatory affairs market will help companies and investors design strategic landscapes.
Outsourcing was the largest segment with a revenue share of 63.89% in 2024. Horizon Databook has segmented the Europe pharmaceutical regulatory affairs market based on in-house, outsourcing covering the revenue growth of each sub-segment from 2018 to 2030.
Reasons to subscribe to Europe pharmaceutical regulatory affairs market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Europe pharmaceutical regulatory affairs market databook
-
Our clientele includes a mix of pharmaceutical regulatory affairs market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of continent-level data and insights on the Europe pharmaceutical regulatory affairs market , including forecasts for subscribers. This continent databook contains high-level insights into Europe pharmaceutical regulatory affairs market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Europe pharmaceutical regulatory affairs market size, by country, 2018-2030 (US$M)
Europe Pharmaceutical Regulatory Affairs Market Outlook Share, 2024 & 2030 (US$M)
Related industry reports
Related statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
